Further strengthening the recognized Healthcare expertise within its Corporate Finance team, Degroof Petercam Investment Banking recruits former Celyad-CFO Patrick Jeanmart as Managing Director and Global Head of Healthcare. Patrick Jeanmart will take up his new role as of July 1st.
As part of the 140-expert strong Investment Banking team, Patrick will contribute to the further development of Degroof Petercam’s healthcare franchise, with a geographic focus on Europe and the US but with a global reach. In addition to his overall expertise and knowledge of the healthcare industry, his experience in obtaining a secondary listing on Nasdaq will be instrumental for Degroof Petercam in servicing its clients.
François Wohrer, Group Head of Degroof Petercam Investment Banking : “In healthcare, even more than in other industries, entrepreneurship and a long-term vision are absolute prerequisites for success. It comes as no surprise that Degroof Petercam, who has these two values cemented in its DNA, has a strong position as financial advisor to the healthcare industry. By appointing a global head of Healthcare, we further underline both the strategic importance this sector has for us, as well as the international dynamic at Degroof Petercam Investment Banking.”
Patrick Jeanmart, newly appointed Managing Director and Global Head of Healthcare, Degroof Petercam Investment Banking: “I’m extremely pleased to join one of the leading investment banks in Europe and a team of highly recognized professionals. I look forward to working with my new colleagues to further extend the reach and footprint of Degroof Petercam Investment Banking in healthcare, in Europe and in the US.”
(story continues under the picture)
Patrick Jeanmart has almost 25 years of experience in finance positions.
Over the last 12 years, he served as chief financial officer of Celyad, a Belgian biotechnology company listed on Euronext and Nasdaq. Patrick started his career at Deloitte where he spent six years as financial auditor. He then joined the IBA Group where he served in numerous senior financial positions in Belgium and the US, before joining Celyad in 2007.
Degroof Petercam Investment Banking and Healthcare
Healthcare is since long a key industry for Degroof Petercam Investment Banking, which can count many biotechnology and life science companies amongst its long-term clients. These companies rely on Degroof Petercam for services in financial markets, financial advisory and mergers and acquisitions.
The team of sell-side analysts focusing on Healthcare consists of Stéphanie Put, PhD and Benoit Louage, PhD. In the weeks to come, a third analyst will join the team. Just like Stéphanie and Benoit, he has a background in both Science and Finance.Together, they follow-up healthcare companies such as argenx, Biocartis, Galapagos, Mithra, Poxel, UCB and others.
About Degroof Petercam Investment Banking
Degroof Petercam Investment Banking employs over 140 experts in financial markets, financial advisory and mergers and acquisitions. They service institutional investors, companies and entrepreneurs from offices in Brussels, Paris, Lyon, Luxemburg, Barcelona and Amsterdam.
As member of IMAP, a leading partnership of midcap M&A advisories located in 39 countries, and as its exclusive partner for Belgium and France, Degroof Petercam Investment Banking has a global reach.